Alseres Pharmaceuticals Presents Inosine And Dopamine Transporter (DAT) Blocker Preclinical Data At The ASENT Conference

<p>Mar. 11, 2008 (Medical News Today)- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) announced that data from preclinical studies of the Company’s nerve repair candidate, Inosine, and DAT Blocker product candidates from its neurodegeneration program were presented at the ASENT conference, March 6-8, 2008 in Arlington, VA…</p>